CARDS IN HAEMATOLOGICAL (154)
+10 or trisomy 10 (solely)
+11 or trisomy 11 (solely) KMT2A
+14 or trisomy 14 (solely)
+19 or trisomy 19
+21 or trisomy 21
+22 or trisomy 22 (solely?)
+4 or trisomy 4
+6 or trisomy 6
+8 or trisomy 8
+9 or trisomy 9
+X solely in lymphomas
+X solely in myeloid malignancies
-20 or monosomy 20
-7/del(7q) in adults
8p11 myeloproliferative syndrome (FGFR1)
ABL1/PRRC2B (9q34)
Acute Lymphoblastic Leukemia with Hypereosinophilia
Acute myeloid leukemia with myelodysplasia related changes
Aggressive natural killer leukemia (ANKL)
ALK -positive diffuse large B-cell lymphoma
Alpha heavy chain disease
Anaplastic B-cell lymphoma
Anaplastic large cell lymphoma (ALCL)
Anaplastic large cell lymphoma, ALK-negative
Angioimmunoblastic T-cell lymphoma
Atypical Chronic Myeloid Leukemia (aCML)
B-cell prolymphocytic leukemia (B-PLL)
Biphenotypic Acute Leukaemia (BAL)
Burkitts lymphoma (BL)
Centroblastic lymphoma
Chronic Eosinophilic Leukemia-Not Otherwise Specified (CEL-NOS)
Idiopathic Hypereosinophilic Syndrome (IHES)
Chronic myelogenous leukaemia (CML)
Classical Hodgkin lymphoma
Classical Hodgkin lymphoma type PTLD
Classification of acute myeloid leukemias
Classification of Hodgkin lymphoma over years
Classification of T-Cell disorders
del (5q) solely in Myelodysplastic syndrome
del(13q) in myeloid malignancies
del(20q) in myeloid malignancies
del(5q) in myeloid neoplasms
del(9p) in Acute Lymphoblastic Leukemia
del(9q) solely
der(1;7)(q10;p10)
Diffuse large cell lymphoma
Disseminated Juvenile Xanthogranuloma
DLBCL subtype: Extranodal lymphoma
Double Hit Lymphoma (DHL)
Triple Hit Lymphoma (THL)
Early T-cell precursor acute lymphoblastic leukemia
EBV positive DLBCL, NOS
Essential Thrombocythemia (ET)
Extranodal NK/T-cell lymphoma, nasal type (ENKL)
Florid follicular hyperplasia PTLD
Follicular dendritic cell in lymphomas of follicular origin
Follicular Dendritic Cell Sarcoma
Follicular lymphoma (FL)
Follicular lymphomas of germinal center (B- or T-cell) origin
Gamma heavy chain disease
Germinal center B-cell-like diffuse Large B-cell Lymphoma (GCB) DLBCL
Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-V)
Hepatosplenic T-cell lymphoma (HSTCL)
Histiocyte-rich B-cell lymphoma
Histiocytic Sarcoma
HIV-associated lymphomas
Hodgkin lymphoma
i(17q) solely in myeloid malignancies
i(18)(q10)
idic(X)(q13)
Immunoblastic lymphoma
In situ follicular neoplasia
Indeterminate Dendritic Cell Tumor
Infectious mononucleosis-like PTLD
Interdigitating Dendritic Cell Sarcoma
Intestinal T-cell lymphoma
inv(10)(q11q11) NCOA4/RET
inv(16)(p13q22) CBFB/MYH11
t(16;16)(p13;q22) CBFB/MYH11
del(16)(q22) CBFB/MYH11
inv(3)(q21q26) RPN1/MECOMt(3;3)(q21;q26) RPN1/MECOMins(3;3)(q26;q21q26) RPN1/MECOM
Lymphoepithelioid lymphoma
Lymphoplasmacytic lymphoma
Mantle cell lymphoma
Mediastinal Gray Zone Lymphoma
Mixed phenotype acute leukemia (MPAL)
Monomorphic PTLD (B- and T/NK-cell types)
Mu heavy chain disease
Mucosa-associated lymphoid tissue (MALT) lymphoma
Multiple Myeloma
Multiple myeloma (published in 2004)
Mycosis fungoides/Sezarys syndrome
Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)
Myelodysplastic/myeloproliferative neoplasms
Myeloid sarcoma
Myeloid/Lymphoid neoplasms with abnormalities of PDGFRA
Myeloid/Lymphoid neoplasms with abnormalities of PDGFRB
Nodal marginal zone lymphoma (NMZL)
Nodular lymphocyte-predominant Hodgkin lymphoma
Nodular sclerosis classical Hodgkin lymphoma (NScHL)
Pediatric-type Follicular Lymphoma
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
Plasma cell leukemia (PCL)
Plasma Cell Neoplasms: an overview
Plasmacytoma (Solitary bone plasmacytoma, extramedullary plasmacytoma)
Polyclonal B Lymphocytosis with Binucleated Lymphocytes (PPBL)
Polymorphic PTLD
Primary cutaneous CD30+ anaplastic large cell lymphoma
Primary cutaneous DLBCL, leg type
Primary DLBCL of the central nervous system (CNS)
Primary mediastinal B-cell lymphoma (PMBL)
Refractory anemia with ringed sideroblasts (RARS)
Small lymphocytic lymphoma
Splenic lymphoma with villous lymphocytes (SLVL) in 2005
Subcutaneous panniculitis-like T-cell lymphoma
Systemic mast cell disease (SMCD)
t(10;11)(p12;q21) PICALM/MLLT10
t(10;11)(p12;q23) KMT2A/MLLT10
t(11;12)(p15;q13) NUP98/RARG
t(11;17)(q23;q12-21) KMT2A/MLLT6
t(11;17)(q23;q21) ZBTB16/RARA
t(11;19)(q23;p13.1) KMT2A/ELL
t(11;19)(q23;p13.3) KMT2A/MLLT1
t(12;22)(p13;q12) MN1/ETV6
t(14;22)(q32;q11) IGH/IGL
t(15;17)(q24;q21) PML/RARA
t(16;21)(p11;q22) FUS/ERG
t(17;17)(q21;q21) STAT5B/RARA
dup(17)(q12q21) STAT5B/RARA
t(1;11)(p32;q23) KMT2A/EPS15
t(1;11)(q21;q23) KMT2A/MLLT11
t(1;3)(p36;q21) PSMD2/PRDM16 ???
t(2;11)(p21;q23) KMT2A/?
t(3;12)(q26;p13) ETV6/MECOM
t(3;12)(q26;p13) ETV6/EVI1
t(3;16)(q21;q22)
t(3;21)(q26;q22) RUNX1/MECOM
t(3;5)(q21;q31)
t(3;5)(q25;q34) NPM1/MLF1
t(4;11)(q21;q23) KMT2A/AFF1
t(4;12)(q12;p13) CHIC2/ETV6
t(5;12)(q33;p13) ETV6/PDGFRB
t(5;17)(q35;q21) NPM1/RARA
t(5;7)(q33;q11) HIP1/PDGFRB
t(6;11)(q27;q23) KMT2A/AFDN
t(6;8)(q27;p12) FGFR1OP/FGFR1
t(6;9)(p22;q34) DEK/NUP214
t(7;11)(p15;p15) NUP98/HOXA9
t(7;14)(p15;q32)
t(8;14)(q11;q32) IGH/CEBPD
t(8;16)(p11;p13) KAT6A/CREBBP
t(8;21)(q22;q22) RUNX1/RUNX1T1
t(9;12)(q34;p13) ETV6/ABL1
t(9;22)(q34;q11) BCR/ABL1 in ALL
t(9;22)(q34;q11) BCR/ABL1 in CML
T-cell large granular lymphocyte leukaemia
T-cell prolymphocytic leukemia (T-PLL)
T-cell/histiocyte rich large B-cell lymphoma
Waldenstrom macroglobulinemia
Y loss in leukemia